Citrulline Supplementation Improves Aortic Vasodilation and Prevents Aortic Thickening Only in Female Rats
Katia Martinez-Gonzalez, Patricia Campos-Bedolla, Claudia Patlán-Lozano, Eduardo Almeida-Gutierrez, Leonor Serrano-Cuevas, Alam Palma-Guzman, Octavio Arellano-Escudero, Paola Garcia-delaTorreBackground:
Aging is associated with endothelial dysfunction and vascular remodeling, partly due to reduced nitric oxide (NO) bioavailability.
Methods:
Eight-month-old male and female Sprague-Dawley rats were randomly assigned to control or treatment groups. The treated animals received oral malate citrulline (1 g/kg/d) for 12 weeks. We isolated thoracic aortas for histological and morphometric analyses, including tunica media thickness and intima/media ratio. We assessed vascular reactivity in vitro using isolated aortic rings in an organ bath system, measuring acetylcholine (ACh)-induced relaxation following phenylephrine-induced contraction.
Results:
Citrulline supplementation significantly improved ACh-induced vasorelaxation in female rats compared with female controls (55.14% ± 4.8% vs 42.4% ± 4.3%,
Conclusions:
Citrulline supplementation improves endothelium-dependent vasodilation and may preserve aortic structural integrity in female rats but not in males. These findings suggest a sex-dependent vascular response to citrulline, potentially mediated by differences in NO signaling and hormonal regulation. Citrulline may represent a therapeutic strategy to improve vascular function during aging, particularly in females.
Clinical Impact:
The findings may guide clinical trials investigating how hormonal status and nitric oxide signaling affect the efficacy of citrulline supplementation in female patients. Ultimately, these insights could establish citrulline as a targeted, preventive intervention to preserve aortic structural integrity and reduce cardiovascular disease risk in the aging female population.